Cargando…
PAGln, an Atrial Fibrillation-Linked Gut Microbial Metabolite, Acts as a Promoter of Atrial Myocyte Injury
Phenylacetylglutamine (PAGln), a gut microbiota (GM)-derived metabolite, is associated with cardiovascular disease. Studies have shown that disordered GM participated in the progression of atrial fibrillation (AF), but the relationship between PAGln and AF is unclear. This study investigated the cha...
Autores principales: | Fang, Chen, Zuo, Kun, Jiao, Kaicheng, Zhu, Xiaoming, Fu, Yuan, Zhong, Jiuchang, Xu, Li, Yang, Xinchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405855/ https://www.ncbi.nlm.nih.gov/pubmed/36009014 http://dx.doi.org/10.3390/biom12081120 |
Ejemplares similares
-
Alterations of gut viral signals in atrial fibrillation: complex linkage with gut bacteriome
por: Zuo, Kun, et al.
Publicado: (2022) -
Elevated plasma Ninjurin-1 levels in atrial fibrillation is associated with atrial remodeling and thromboembolic risk
por: Fang, Chen, et al.
Publicado: (2022) -
Aggravated Gut Microbiota and Metabolomic Imbalances Are Associated with Hypertension Patients Comorbid with Atrial Fibrillation
por: Fang, Chen, et al.
Publicado: (2022) -
Suppression of the gut microbiota–bile acid–FGF19 axis in patients with atrial fibrillation
por: Zuo, Kun, et al.
Publicado: (2023) -
Association between Gut Microbiota Dysbiosis and the CHA2DS2-VASc Score in Atrial Fibrillation Patients
por: Fang, Chen, et al.
Publicado: (2022)